GD

Grand Decade Developments

Asia, Hong Kong Island, Hong Kong, Central

Description

Grand Decade Developments is an affiliate of China Grand Pharmaceuticals.

Investor Profile

Grand Decade Developments has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Post Ipo Equity rounds (top funding stages).
  • Majority of deals are located in Israel.
  • Strong thematic focus on Health Care, Medical Device.

Stage Focus

  • Post Ipo Equity (100%)

Country Focus

  • Israel (100%)

Industry Focus

  • Health Care
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Grand Decade Developments frequently co-invest with?

Regah Ventures
North America, New York, United States, New York
Co-Investments: 1
OurCrowd
Asia, Yerushalayim, Israel, Jerusalem
Co-Investments: 1
YG
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
Medison Ventures
Asia, HaMerkaz, Israel, Petah Tiqva
Co-Investments: 1

Which angels does Grand Decade Developments often collaborate with?

RC
Europe, England, United Kingdom, London
Shared Deals: 1
AP
North America, New York, United States, New York
Shared Deals: 1

What are some of recent deals done by Grand Decade Developments?

Alpha Tau Medical

Tel Aviv, Tel Aviv, Israel

Alpha Tau Medical focuses on research, development and commercialization of Alpha DaRT for the treatment of solid cancer tumors.

Health CareMedical Device
Post Ipo EquityMar 8, 2022
Amount Raised: $92,000,000